Efficacy and Safety of the Compound of Candesartan Cilexetial and Hydrochlorothiazide in Patients with Essential Hypertension
JIA You-hong,MING Guang-hua,Wang Yang,HE Qing,YANG Xin-chun,HUA Qi,CHEN Jun-zhu,BIAN Wen-yan,HU Ying,QANG Jian,ZHANG Yin-feng,LIU Hong,FANG Li,LIU Wei,WANG Fang,GAO Ming-ming,LI Jing,YAO Xue-yan,LI Yi-shi
DOI: https://doi.org/10.3969/j.issn.1673-7245.2008.02.009
2008-01-01
Abstract:Objective To evaluate the efficacy and safety of combination of candesartan cilexetial and hydrochlorothiazide (16.0 mg/12.5 mg) in patients with mild and moderate hypertension.Methods A 8 weeks,multicenter, double-blind,randomized,parallel-group study was carried out.After 2 weeks wash-out phase,treatment started with once-daily 8 mg candesartan cilexetil in the 392 patients for 4 weeks(phase 1 study);if target sitting diastolic BP(SeDBP90 mm Hg) was not achieved,the dose were titrated to candesartan 16 mg alone or candesartan 16.0 mg/hydrochlorothiazide 12.5 mg pill once daily for 8 weeks(phase 2 study).Results The reduction of BP were 10.2±10.6/6.5±5.7 mm Hg after 4 weeks treatment of 8 mg candesartan cilexetial alone(n=353),only 54 (15.3%) patients achieved the target DBP.During the consequential 8 weeks treatment,the antihypertensive effect of combined treatment(n=134) was much greater than that by candesartan alone(n=142)(11.1±11.2/10.7±6.6 mm Hg vs 7.8±11.1/7.8±6.3 mm Hg,P0.01).The number of patients who achieved the target DBP were 73/142(51.4%) by monotherapy vs 107/134(79.9%) by combined treatment(P0.01).Patients were well tolerated in both groups with no difference in drug-related adverse events.Conclusion The combined candesartan cilexetiain and hydrochlorothiazide treatment is more effective and well tolerated in patients with mild and molderate hypertension than that by candesartan monotherapy.